{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T19:56:36Z","timestamp":1675886196833},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T00:00:00Z","timestamp":1381881600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00120-013-3252-z","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T09:58:07Z","timestamp":1381744687000},"page":"1556-1563","source":"Crossref","is-referenced-by-count":6,"title":["Neoadjuvante, adjuvante und palliative Chemotherapie des Peniskarzinoms"],"prefix":"10.1007","volume":"52","author":[{"given":"C.","family":"Protzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.K.","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.W.","family":"Hakenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Retz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,16]]},"reference":[{"key":"3252_CR1","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00120-009-2108-z","volume":"48","author":"Protzel","year":"2009","unstructured":"Protzel C, Ruppin S, Milerski S et al (2009) The current state of the art of chemotherapy of penile cancer: Results of a nationwide survey of German clinics. Urologe A 48(12):1495\u20131498","journal-title":"Urologe A"},{"key":"3252_CR2","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-5347(17)38069-2","volume":"146","author":"Dexeus","year":"1991","unstructured":"Dexeus FH, Logothetis CJ, Sella A et al (1991) Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract. J Urol 146(5):1284\u2013128700","journal-title":"J Urol"},{"key":"3252_CR3","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0022-5347(01)62402-9","volume":"160","author":"Corral","year":"1998","unstructured":"Corral DA, Sella A, Pettaway CA et al (1998) Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. J Urol 160(5):1770\u20131774","journal-title":"J Urol"},{"key":"3252_CR4","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0022-5347(05)68815-5","volume":"161","author":"Haas","year":"1999","unstructured":"Haas GP, Blumenstein BA, Gagliano RG et al (1999) Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 161(6):1823\u20131825","journal-title":"J Urol"},{"key":"3252_CR5","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1464-410X.2006.06496.x","volume":"98","author":"Hakenberg","year":"2006","unstructured":"Hakenberg OW, Nippgen JB, Froehner M et al (2006) Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma. BJU Int 98(6):1225\u20131227","journal-title":"BJU Int"},{"key":"3252_CR6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/02841868809094366","volume":"27","author":"Pizzocaro","year":"1988","unstructured":"Pizzocaro G, Piva L (1988) Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 27(6b):823\u2013824","journal-title":"Acta Oncol"},{"key":"3252_CR7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.eururo.2008.07.014","volume":"55","author":"Pizzocaro","year":"2008","unstructured":"Pizzocaro G, Nicolai N, Milani A (2008) Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results. Eur Urol 55(3):546\u2013551","journal-title":"Eur Urol"},{"key":"3252_CR8","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","volume":"28","author":"Pagliaro","year":"24","unstructured":"Pagliaro LC, Williams DL, Daliani D et al () Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 28(24):3851\u20133857","journal-title":"J Clin Oncol"},{"key":"3252_CR9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00120-012-3004-5","volume":"52","author":"Protzel","year":"2013","unstructured":"Protzel C, Hakenberg OW (2013) Penile carcinoma: diagnosis and therapy. Urologe A 52(1):87\u201398","journal-title":"Urologe A"},{"key":"3252_CR10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-5347(17)40590-8","volume":"141","author":"Gagliano","year":"1989","unstructured":"Gagliano RG, Blumenstein BA, Crawford ED et al (1989) Cis-Diamminedichloroplatinum in the treatment of advanced epidermoid carcinoma of the penis: a Southwest Oncology Group Study. J Urol 141(1):66\u201367","journal-title":"J Urol"},{"key":"3252_CR11","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/1097-0142(197911)44:5<1563::AID-CNCR2820440503>3.0.CO;2-S","volume":"44","author":"Sklaroff","year":"1979","unstructured":"Sklaroff RB, Yagoda A (1979) Cis-diamminedichloride platinum II (DDP) in the treatment of penile carcinoma. Cancer 44(5):1563\u20131565","journal-title":"Cancer"},{"key":"3252_CR12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0090-4295(93)90273-D","volume":"42","author":"Kattan","year":"1993","unstructured":"Kattan J, Culine S, Droz JP et al (1993) Penile cancer chemotherapy: twelve years\u2018 experience at Institut Gustave-Roussy. Urology 42(5):559\u2013562","journal-title":"Urology"},{"key":"3252_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000176016","volume":"82","author":"Protzel","year":"2009","unstructured":"Protzel C, Hakenberg OW (2009) Chemotherapy in patients with penile carcinoma. Urol Int 82(1):1\u20137","journal-title":"Urol Int"},{"key":"3252_CR14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/1097-0142(19900201)65:3<433::AID-CNCR2820650310>3.0.CO;2-G","volume":"65","author":"Hussein","year":"1990","unstructured":"Hussein AM, Benedetto P, Sridhar KS (1990) Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 65(3):433\u2013438","journal-title":"Cancer"},{"key":"3252_CR15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1464-410X.2012.11453.x","volume":"110","author":"Di","year":"2012","unstructured":"Di Lorenzo G, Buonerba C, Federico P et al (2012) Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis. BJU Int 110(11 Pt B):661\u2013666","journal-title":"BJU Int"},{"key":"3252_CR16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0022-5347(17)37327-5","volume":"147","author":"Shammas","year":"1992","unstructured":"Shammas FV, Ous S, Fossa SD (1992) Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 147(3):630\u2013632","journal-title":"J Urol"},{"key":"3252_CR17","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/annonc\/mdn149","volume":"19","author":"Theodore","year":"2008","unstructured":"Theodore C, Skoneczna I, Bodrogi I et al (2008) A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Ann Oncol 19(7):1304\u20131307","journal-title":"Ann Oncol"},{"key":"3252_CR18","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.eururo.2010.01.039","volume":"57","author":"Pizzocaro","year":"2009","unstructured":"Pizzocaro G, Algaba F, Horenblas S et al (2009) EAU Penile Cancer Guidelines 2009. Eur Urol 57(6):1002\u20131012","journal-title":"Eur Urol"},{"key":"3252_CR19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.eururo.2009.02.021","volume":"55","author":"Protzel","year":"2009","unstructured":"Protzel C, Alcaraz A, Horenblas S et al (2009) Lymphadenectomy in the surgical management of penile cancer. Eur Urol 55(5):1075\u20131088","journal-title":"Eur Urol"},{"key":"3252_CR20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ju.0000062829.43654.5e","volume":"170","author":"Culkin","year":"2003","unstructured":"Culkin DJ, Beer TM (2003) Advanced penile carcinoma. J Urol 170(2 Pt 1):359\u2013365","journal-title":"J Urol"},{"key":"3252_CR21","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.eururo.2007.02.006","volume":"52","author":"Leijte","year":"2007","unstructured":"Leijte JA, Kerst JM, Bais E et al (2007) Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol 52(2):488\u2013494","journal-title":"Eur Urol"},{"key":"3252_CR22","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/annonc\/mdn149","volume":"19","author":"Theodore","year":"2008","unstructured":"Theodore C, Skoneczna I, Bodrogi I et al (2008) A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Ann Oncol 19(7):1304\u20131307","journal-title":"Ann Oncol"},{"key":"3252_CR23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000480874","volume":"32","author":"Pizzocaro","year":"1997","unstructured":"Pizzocaro G, Piva L, Bandieramonte G, Tana S (1997) Up-to-date management of carcinoma of the penis. Eur Urol 32(1):5\u201315","journal-title":"Eur Urol"},{"key":"3252_CR24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.juro.2011.03.117","volume":"186","author":"Franks","year":"2","unstructured":"Franks KN, Kancherla K, Sethugavalar B et al () Radiotherapy for node positive penile cancer: experience of the Leeds teaching hospitals. J Urol 186(2):524\u2013529","journal-title":"J Urol"},{"key":"3252_CR25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/0974-7796.102659","volume":"4","author":"Noronha","year":"2012","unstructured":"Noronha V, Patil V, Prabhash K (2012) Role of paclitaxel and platinum based adjuvant chemotherapy in high risk penile cancer. Urology Annals 4(3):150\u2013153","journal-title":"Urology Annals"},{"key":"3252_CR26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00120-006-1273-6","volume":"46","author":"Preis","year":"2007","unstructured":"Preis E, Jakse G (2007) Options in palliative therapy for penile cancer. Urologe A 46(1):49\u201353","journal-title":"Urologe A"},{"key":"3252_CR27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11255-011-0011-1","volume":"44","author":"Heinlen","year":"2012","unstructured":"Heinlen JE, Buethe DD, Culkin DJ (2012) Advanced penile cancer. Int Urol Nephrol 44(1):139\u2013148","journal-title":"Int Urol Nephrol"},{"key":"3252_CR28","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00120-005-0882-9","volume":"44","author":"Paul","year":"2005","unstructured":"Paul R, van Randenborgh H, Scholer S et al (2005) Penile cancer--aftercare with results. How much is necessary? Urologe A 44(9):1031\u20131036","journal-title":"Urologe A"},{"key":"3252_CR29","first-page":"10","volume":"doi","author":"Liu","year":"2013","unstructured":"Liu JY, Li YH, Liu ZW et al (2013) Intraarterial chemotherapy with gemcitabine and cisplatin in locally advanced or recurrent squamous cell carcinoma of the penis. Chin J Cancer doi: 10.5732\/cjc.012.10275. (Epub ahead of print)","journal-title":"Chin J Cancer"},{"key":"3252_CR30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijrobp.2003.11.041","volume":"59","author":"Herbst","year":"2004","unstructured":"Herbst RS (2004) Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 59(2 Suppl):21\u201326","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3252_CR31","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/cncr.24123","volume":"115","author":"Gold","year":"2009","unstructured":"Gold KA, Lee HY, Kim ES (2009) Targeted therapies in squamous cell carcinoma of the head and neck. Cancer 115(5):922\u2013935","journal-title":"Cancer"},{"key":"3252_CR32","doi-asserted-by":"crossref","first-page":"62175","DOI":"10.1371\/journal.pone.0062175","volume":"8","author":"Gou","year":"2013","unstructured":"Gou HF, Li X, Qiu M et al (2013) Epidermal growth factor receptor (EGFR)-RAS signaling pathway in penile squamous cell carcinoma. PLoS One 8(4):62175","journal-title":"PLoS One"},{"key":"3252_CR33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1479-5876-11-161","volume":"11","author":"Di","year":"2013","unstructured":"Di Lorenzo G, Perdona S, Buonerba C et al (2013) Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: a retropective study. J Transl Med 11(1):161","journal-title":"J Transl Med"},{"key":"3252_CR34","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1200\/jco.2010.28.15_suppl.e15022","volume":"28","author":"Carthon","year":"2010","unstructured":"Carthon BC, Pettaway C, Pagliaro LC (2010) Epidermal growth factor receptor (EGFR) targeted therapy in advanced metastatic squamous cell carcinoma (AMSCC) of the penis: updates and molecular analyses.. J Clin Oncol 28(Suppl):15022","journal-title":"J Clin Oncol"},{"key":"3252_CR35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1200\/JCO.2011.34.8367","volume":"29","author":"Necchi","year":"2011","unstructured":"Necchi A, Nicolai N, Colecchia M et al (2011) Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis. J Clin Oncol 29(22):650\u2013652","journal-title":"J Clin Oncol"},{"key":"3252_CR36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/CAD.0b013e328350ead7","volume":"23","author":"Rescigno","year":"2012","unstructured":"Rescigno P, Matano E, Raimondo L et al (2012) Combination of docetaxel and cetuximab for penile cancer: a case report and literature review. Anticancer Drugs 23(5):573\u2013577","journal-title":"Anticancer Drugs"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-013-3252-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-013-3252-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-013-3252-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T23:20:45Z","timestamp":1596669645000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-013-3252-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,16]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["3252"],"URL":"https:\/\/doi.org\/10.1007\/s00120-013-3252-z","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,16]]}}}